electroCore (ECOR) Liabilities and Shareholders Equity (2017 - 2026)
electroCore's (ECOR) quarterly Liabilities and Shareholders Equity came in at $15.5 million in Q1 2026, down 3.48% year-on-year from $16.0 million in Q1 2025, and down 17.06% quarter-over-quarter from $18.7 million in Q4 2025.
electroCore (ECOR) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
electroCore's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $15.5 million for Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 3.48% year-over-year to $15.5 million in Q1 2026; TTM through Mar 2026 was $70.1 million, a 12.25% decrease from a year earlier, with the FY2025 full-year figure at $18.7 million, down 8.81% from the prior year.
- Liabilities and Shareholders Equity retreated to $15.5 million in Q1 2026 per ECOR's latest filing, from $18.7 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $37.2 million in Q1 2022 and bottomed at $13.9 million in Q1 2024.
- The 5-year median for Liabilities and Shareholders Equity is $20.1 million (2023), against an average of $21.0 million.
- Across the five-year window, Liabilities and Shareholders Equity tumbled 57.52% in 2023 and jumped 57.19% in 2024, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $24.8 million in 2022, then tumbled by 34.96% to $16.1 million in 2023, then climbed by 27.13% to $20.5 million in 2024, then retreated by 8.81% to $18.7 million in 2025, then fell by 17.06% to $15.5 million in 2026.
- Per Business Quant, the three latest ECOR Liabilities and Shareholders Equity figures stand at $15.5 million (Q1 2026), $18.7 million (Q4 2025), and $21.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | electroCore | 56,941.08 | -8.77 Mn | 8.36 Mn | 15.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.48 Mn |
| Dec 31, 2025 | 18.67 Mn |
| Sep 30, 2025 | 21.41 Mn |
| Jun 30, 2025 | 14.56 Mn |
| Mar 31, 2025 | 16.04 Mn |
| Dec 31, 2024 | 20.47 Mn |
| Sep 30, 2024 | 21.05 Mn |
| Jun 30, 2024 | 22.36 Mn |
| Mar 31, 2024 | 13.89 Mn |
| Dec 31, 2023 | 16.10 Mn |
| Sep 30, 2023 | 20.11 Mn |
| Jun 30, 2023 | 14.22 Mn |
| Mar 31, 2023 | 18.30 Mn |
| Dec 31, 2022 | 24.76 Mn |
| Sep 30, 2022 | 29.49 Mn |
| Jun 30, 2022 | 33.48 Mn |
| Mar 31, 2022 | 37.18 Mn |
| Dec 31, 2021 | 42.83 Mn |
| Sep 30, 2021 | 47.57 Mn |
| Jun 30, 2021 | 31.30 Mn |